These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36693543)

  • 21. Single Injection Technique Prolotherapy for Hypermobility Disorders of TMJ Using 25 % Dextrose: A Clinical Study.
    Majumdar SK; Krishna S; Chatterjee A; Chakraborty R; Ansari N
    J Maxillofac Oral Surg; 2017 Jun; 16(2):226-230. PubMed ID: 28439165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficacy of occlusal splint and botulinum toxin therapies in patients with temporomandibular disorders with sleep bruxism.
    Hosgor H; Altindis S; Sen E
    J Orofac Orthop; 2024 May; 85(Suppl 1):102-108. PubMed ID: 37843582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of hypertonic dextrose injection (prolotherapy) in temporomandibular joint dysfunction: a systematic review and meta-analysis.
    Sit RW; Reeves KD; Zhong CC; Wong CHL; Wang B; Chung VC; Wong SY; Rabago D
    Sci Rep; 2021 Jul; 11(1):14638. PubMed ID: 34282199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of injection of botulinum toxin on lateral pterygoid muscle used together with the arthroscopy in patients with anterior disk displacement of the temporomandibular joint.
    Arinci A; Güven E; Yazar M; Başaran K; Keklik B
    Kulak Burun Bogaz Ihtis Derg; 2009; 19(3):122-9. PubMed ID: 19857189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Change of site of intra-articular injection of hypertonic dextrose resulted in different effects of treatment.
    Fouda AA
    Br J Oral Maxillofac Surg; 2018 Oct; 56(8):715-718. PubMed ID: 30107954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of IncobotulinumtoxinA Injection on Myalgia and Arthralgia in Patients Undergoing Temporomandibular Joint Arthroscopy: A Randomized Controlled Trial.
    Ângelo DF; Sanz D; Maffia F; Cardoso HJ
    Toxins (Basel); 2023 Jun; 15(6):. PubMed ID: 37368677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum Toxin for Treating Temporomandibular Disorders: What is the Evidence?
    Delcanho R; Val M; Guarda Nardini L; Manfredini D
    J Oral Facial Pain Headache; 2022; 36(1):6-20. PubMed ID: 35298571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dextrose prolotherapy on internal derangement of the temporomandibular joint.
    Mohammed MR; Hamad SA; Al-Dawoody AD; Shehab AA; Ahmed OS
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):4883-4889. PubMed ID: 37318462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of prolotherapy in comparison with occlusal splints in treating internal derangement of the temporomandibular joint - A randomized controlled trial.
    Priyadarshini S; Gnanam A; Sasikala B; Elavenil P; Raja Sethupathy Cheeman S; Mrunalini R; Krishna Kumar Raja VB
    J Craniomaxillofac Surg; 2021 Jan; 49(1):24-28. PubMed ID: 33279397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does glucosamine, chondroitin sulfate, and methylsulfonylmethane supplementation improve the outcome of temporomandibular joint osteoarthritis management with arthrocentesis plus intraarticular hyaluronic acid injection. A randomized clinical trial.
    Cömert Kılıç S
    J Craniomaxillofac Surg; 2021 Aug; 49(8):711-718. PubMed ID: 33685850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Preoperative Intramuscular Injection of Botulinum Toxin A on Pain and Mouth Opening After Surgical Intervention in Temporomandibular Joint Ankylosis Cases: A Controlled Clinical Trial.
    Shandilya S; Mohanty S; Sharma P; Chaudhary Z; Kohli S; Kumar RD
    J Oral Maxillofac Surg; 2020 Jun; 78(6):916-926. PubMed ID: 32171600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Prolotherapy in Temporomandibular Joint Disorders: An Exploratory Study.
    Dasukil S; Shetty SK; Arora G; Degala S
    J Maxillofac Oral Surg; 2021 Mar; 20(1):115-120. PubMed ID: 33584052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin used to treat recurrent dislocation of the temporomandibular joint in a patient with osteoporosis.
    Oztel M; Bilski WM; Bilski A
    Br J Oral Maxillofac Surg; 2017 Jan; 55(1):e1-e2. PubMed ID: 27256802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Autologous Blood Injection and Dextrose Prolotherapy in the Treatment of Chronic Recurrent Temporomandibular Dislocation: A Randomized Clinical Trial.
    Chhapane A; Wadde K; Sachdev SS; Barai S; Landge J; Wadewale M
    J Maxillofac Oral Surg; 2024 Apr; 23(2):278-284. PubMed ID: 38601242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does Injection of Corticosteroid After Arthrocentesis Improve Outcomes of Temporomandibular Joint Osteoarthritis? A Randomized Clinical Trial.
    Cömert Kiliç S
    J Oral Maxillofac Surg; 2016 Nov; 74(11):2151-2158. PubMed ID: 27376184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin injection for management of temporomandibular joint clicking.
    Emara AS; Faramawey MI; Hassaan MA; Hakam MM
    Int J Oral Maxillofac Surg; 2013 Jun; 42(6):759-64. PubMed ID: 23538215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain.
    Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of temporomandibular joint luxation: a systematic literature review.
    Abrahamsson H; Eriksson L; Abrahamsson P; Häggman-Henrikson B
    Clin Oral Investig; 2020 Jan; 24(1):61-70. PubMed ID: 31729577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Platelet-Rich Plasma and Hyaluronic Acid can Reduce Pain in Patients Undergoing Arthrocentesis for Temporomandibular Joint Osteoarthritis.
    Asadpour N; Shooshtari Z; Kazemian M; Gholami M; Vatanparast N; Samieirad S
    J Oral Maxillofac Surg; 2022 Sep; 80(9):1474-1485. PubMed ID: 35679902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extraoral Versus Intraoral Botulinum Toxin Type A Injection for Management of Temporomandibular Joint Disc Displacement With Reduction.
    Altaweel AA; Elsayed SA; Baiomy AABA; Abdelsadek SE; Hyder AA
    J Craniofac Surg; 2019 Oct; 30(7):2149-2153. PubMed ID: 31232992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.